Cardiovascular toxicity of targeted therapies for cancer: a protocol for an overview of systematic reviews

INTRODUCTION: The introduction of targeted therapies for cancer has contributed to dramatic improvements in patient survival. Nevertheless, several targeted therapies have been associated with ‘off-target’ adverse effects, based on varying levels of evidence. To date, this evidence has not been syst...

Descripción completa

Detalles Bibliográficos
Autores principales: van Leeuwen, Marina T, Luu, Steven, Gurney, Howard, Brown, Martin R, Webber, Kate, Pearson, Sallie-Anne, Hunt, Lee, Vajdic, Claire M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042572/
https://www.ncbi.nlm.nih.gov/pubmed/29950466
http://dx.doi.org/10.1136/bmjopen-2017-021064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042572/
https://www.ncbi.nlm.nih.gov/pubmed/29950466
http://dx.doi.org/10.1136/bmjopen-2017-021064

Ejemplares similares